Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Inter RAO reported for 2024 by IFRS
2/28/25
IRAO
Alrosa reports for 2024 by IFRS
2/28/25
ALRS
Renaissance Insurance reported for 2024 by RAS
2/28/25
RENI
Moscow Exchange in July will launch full-fledged weekend trading
2/28/25
MOEX
Sollers will launch production of pickup truck T9 in the middle of the year
2/28/25
SVAV
Ozon plans to become profitable within 2-3 years
2/28/25
OZON
Sovcombank conducted its debut consumer loan securitization transaction
2/28/25
SVCB
RusHydro reported for 2024 by RAS
2/27/25
HYDR
Bank of Russia resumed additional share issue of Rosdorbank
2/27/25
RDRB
Rosgosstrakh reported for 2024 by RAS
2/27/25
RGSS
«
Previous
2
3
4
5
6
7
8
9
10
11
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 